SA
CVS icon

Strategic Advisors’s CVS Health CVS Stock Holding History

Strategic Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-4,227
Closed -$266K – 205
2024
Q3 		$266K Sell
4,227
-22,533
-84% -$1.31M 0.05% 182
2024
Q2 		$1.58M Sell
26,760
-763
-3% -$47.7K 0.31% 72
2024
Q1 		$2.2M Sell
27,523
-16
-0.1% -$1.22K 0.43% 54
2023
Q4 		$2.17M Sell
27,539
-767
-3% -$54.6K 0.41% 50
2023
Q3 		$1.98M Buy
28,306
+854
+3% +$60.5K 0.39% 57
2023
Q2 		$1.9M Buy
27,452
+3,261
+13% +$232K 0.36% 57
2023
Q1 		$1.8M Sell
24,191
-349
-1% -$29.3K 0.36% 59
2022
Q4 		$2.29M Sell
24,540
-296
-1% -$28.6K 0.51% 46
2022
Q3 		$2.37M Sell
24,836
-761
-3% -$75.3K 0.53% 44
2022
Q2 		$2.37M Sell
25,597
-499
-2% -$48.7K 0.5% 48
2022
Q1 		$2.64M Sell
26,096
-2,953
-10% -$310K 0.46% 48
2021
Q4 		$3M Sell
29,049
-8
-0% -$739 0.43% 51
2021
Q3 		$2.46M Buy
29,057
+1,207
+4% +$101K 0.53% 39
2021
Q2 		$2.32M Buy
27,850
+490
+2% +$40.1K 0.6% 35
2021
Q1 		$2.06M Sell
27,360
-3,365
-11% -$245K 0.6% 38
2020
Q4 		$2.27M Sell
30,725
-1,462
-5% -$95.1K 0.66% 36
2020
Q3 		$1.9M Buy
32,187
+4,620
+17% +$287K 0.64% 35
2020
Q2 		$1.76M Buy
27,567
+653
+2% +$41.1K 0.66% 32
2020
Q1 		$1.6M Buy
26,914
+3,012
+13% +$201K 0.7% 33
2019
Q4 		$1.78M Sell
23,902
-874
-4% -$61.4K 0.62% 46
2019
Q3 		$1.56M Buy
24,776
+11,379
+85% +$674K 0.59% 49
2019
Q2 		$730K Sell
13,397
-567
-4% -$30.5K 0.28% 78
2019
Q1 		$753K Buy
13,964
+9,930
+246% +$613K 0.29% 77
2018
Q4 		$264K Buy
4,034
+3
+0.1% +$224 0.12% 129
2018
Q3 		$317K Sell
4,031
-6,213
-61% -$444K 0.12% 125
2018
Q2 		$659K Sell
10,244
-7,632
-43% -$503K 0.26% 79
2018
Q1 		$1.11M Buy
17,876
+2,130
+14% +$153K 0.46% 59
2017
Q4 		$1.14M Buy
15,746
+4,696
+42% +$341K 0.47% 61
2017
Q3 		$899K Buy
11,050
+9
+0.1% +$712 0.39% 69
2017
Q2 		$888K Buy
11,041
+8
+0.1% +$632 0.41% 71
2017
Q1 		$866K Sell
11,033
-1,536
-12% -$123K 0.41% 72
2016
Q4 		$992K Sell
12,569
-2,207
-15% -$179K 0.52% 64
2016
Q3 		$1.31M Buy
14,776
+1,149
+8% +$108K 0.74% 47
2016
Q2 		$1.3M Buy
13,627
+876
+7% +$87.3K 0.75% 50
2016
Q1 		$1.32M Buy
12,751
+2,350
+23% +$229K 0.75% 50
2015
Q4 		$1.02M Buy
10,401
+151
+1% +$14.8K 0.67% 54
2015
Q3 		$989K Hold
10,250
– – 0.69% 52
2015
Q2 		$1.07M Buy
10,250
+150
+1% +$15.3K 0.69% 53
2015
Q1 		$761K Hold
10,100
– – 0.49% 70
2014
Q4 		$973K Hold
10,100
– – 0.63% 54
2014
Q3 		$804K Hold
10,100
– – 0.53% 67
2014
Q2 		$761K Sell
10,100
-150
-1% -$11.3K 0.49% 70
2014
Q1 		$767K Hold
10,250
– – 0.51% 64
2013
Q4 		$734K Buy
10,250
+1,150
+13% +$73.9K 0.5% 70
2013
Q3 		$516K Hold
9,100
– – 0.42% 75
2013
Q2 		$524K Buy
+9,100
New +$527K 0.47% 69

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Strategic Advisors's CVS Position: Q4 2024 in Review

Strategic Advisors sold out of CVS Health (CVS) in Q4 2024, closing a stake of 4,227 shares — an estimated $266K sold.

Strategic Advisors first reported a position in CVS in Q2 2013 and held it in 46 quarters. The position peaked at $3M in Q4 2021. 1,668 funds tracked by Wall St. Rank hold CVS as of Q4 2024.

  • Strategic Advisors reported no remaining CVS Health position as of Q4 2024 after selling out during the quarter.
  • Strategic Advisors sold 4,227 CVS Health shares in Q4 2024, an estimated $266K.
  • Strategic Advisors first reported a position in CVS Health in Q2 2013 and held it in 46 quarters.
  • Strategic Advisors's CVS Health position peaked at $3M in Q4 2021.
  • 1,668 funds tracked by Wall St. Rank held CVS Health as of Q4 2024.

Based on Strategic Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.